Kentaro Nakashima

7PUBLICATIONS
35CO-AUTHORS
Child and adolescent developmentRegenerative medicine (incl. stem cells)AutoimmunityPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 05, 2024
Azacitidine treatment for myeloid leukemia associated with Down syndrome: A nationwide retrospective study in Japan.

Shota Kato, Kentaro Nakashima, Genki Yamato

|Jun 25, 2024
The immunoreactive signature of monocyte-derived dendritic cells from patients with Down syndrome.

Kentaro Nakashima, Takashi Imai, Akira Shiraishi

|May 03, 2023
TRK-inhibitor control of an NTRK-rearranged spindle cell tumor with malignant transformation in an adolescent.

Naoko Higuchi, Yuko Honda, Yuhki Koga

|Feb 03, 2023
Survival outcomes of children with relapsed or refractory myeloid leukemia associated with Down syndrome.

Nikhil Raghuram, Daisuke Hasegawa, Kentaro Nakashima

Pageof 2